Alferez, Eferen A.
HRN: 22-58-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/08/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/08/2023
02/15/2023
IV
4.5g
Q6
CAP-MR; T/C PTB Laryngitis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes